1.1 Nutrition Screening & Validated Risk Tools

1.1 Nutrition Screening & Validated Risk Tools

Clinical Core: Nutrition screening is a rapid triage procedure designed to detect individuals who are malnourished or at risk of developing malnutrition, mandated by The Joint Commission within 24 hours of inpatient hospital admission. Screening identifies patients requiring a formal, comprehensive nutrition assessment by a specialized clinician. Validated instruments—including MUST, NRS-2002, NUTRIC, MNA-SF, and MST—must be selected based on clinical setting, target patient population, and diagnostic accuracy.

Screening Versus Comprehensive Nutrition Assessment

Clinical nutrition practice draws a sharp, mandatory distinction between nutrition screening and comprehensive nutrition assessment. Confusing these two distinct clinical processes undermines patient safety, delays therapeutic intervention, and misallocates specialized multidisciplinary clinical resources.

Regulatory and Accreditation Mandates: The Joint Commission (TJC)

The Joint Commission (TJC) standard PC.01.02.01 mandates that all acute care inpatients undergo nutrition screening within 24 hours of hospital admission. While TJC establishes this strict operational timeframe, it does not prescribe a single proprietary instrument. Instead, accredited healthcare institutions are required to select a validated screening tool appropriate for their specific patient demographics, establish defined clinical score thresholds, and formulate an explicit institutional policy specifying when and how a high-risk screen triggers a formal consultation with a specialized nutrition clinician.

Diagnostic Performance Metrics: Sensitivity, Specificity, and Reliability

A clinically effective screening tool must balance diagnostic precision against practical bedside usability:

• Sensitivity: The proportion of truly malnourished or at-risk patients correctly identified by the tool (true-positive rate). High sensitivity is essential in screening to prevent false negatives, ensuring vulnerable patients are not overlooked.
• Specificity: The proportion of well-nourished patients correctly categorized as low risk (true-negative rate). Adequate specificity prevents false-positive alarms from overwhelming registered dietitians and clinical teams with unnecessary formal assessments.
• Inter-Rater Reliability: The degree of agreement between different evaluators assessing the same patient (measured by Cohen's kappa coefficient $\kappa$). An effective screening tool must demonstrate substantial or near-perfect inter-rater reliability ($\kappa > 0.60\text{--}0.80$) across rotating nursing shifts and diverse skill levels.

---

Validated Nutrition Screening Instruments

Validated screening instruments have been rigorously evaluated against comprehensive clinical benchmarks. Selection of an inappropriate tool (for example, applying a geriatric outpatient tool to a critically ill ICU patient) introduces severe diagnostic error.

1. Malnutrition Universal Screening Tool (MUST)

Developed by the British Association for Parenteral and Enteral Nutrition (BAPEN), the MUST is a five-step algorithm validated across outpatient, community, subacute, and acute inpatient settings. It evaluates three independent clinical parameters:

1. BMI Score:
   • $\text{BMI} > 20.0\text{ kg/m}^2 = 0\text{ points}$
   • $\text{BMI } 18.5\text{--}20.0\text{ kg/m}^2 = 1\text{ point}$
   • $\text{BMI} < 18.5\text{ kg/m}^2 = 2\text{ points}$
2. Unplanned Weight Loss Score (past 3 to 6 months):
   • Unplanned loss $< 5\% = 0\text{ points}$
   • Unplanned loss $5\%\text{--}10\% = 1\text{ point}$
   • Unplanned loss $> 10\% = 2\text{ points}$
3. Acute Disease Effect Score:
   • If the patient is acutely ill and there has been, or is likely to be, no nutritional intake for $> 5\text{ days} = \text{add } 2\text{ points}$.

Scoring and Clinical Triage:

• Score 0 (Low Risk): Routine clinical care; repeat screening weekly in hospital or monthly in care homes.
• Score 1 (Medium Risk): Observation; document dietary intake via calorie counts for 3 days; re-evaluate.
• Score $\ge 2$ (High Risk): Treat; immediate referral to a registered dietitian or nutrition support team; initiate clinical nutritional support and oral nutritional supplements (ONS).

2. Nutritional Risk Screening 2002 (NRS-2002)

Endorsed by the European Society for Clinical Nutrition and Metabolism (ESPEN), the NRS-2002 was derived from a systematic analysis of 128 randomized controlled trials to specifically identify hospitalized adult patients who will benefit from nutritional intervention. It consists of an initial 4-question prescreen, followed by a detailed matrix scoring two distinct clinical domains (each graded 0 to 3 points), plus an age adjustment:

1. Impaired Nutritional Status (Score 0–3):
   • Absent (0): Normal nutritional status.
   • Mild (1): Weight loss $> 5\%$ in 3 months OR food intake $50\%\text{--}75\%$ of normal requirements in the preceding week.
   • Moderate (2): Weight loss $> 5\%$ in 2 months OR BMI $18.5\text{--}20.5\text{ kg/m}^2$ with impaired general condition OR food intake $25\%\text{--}50\%$ of normal requirements in the preceding week.
   • Severe (3): Weight loss $> 5\%$ in 1 month ($> 15\%$ in 3 months) OR $\text{BMI} < 18.5\text{ kg/m}^2$ with impaired general condition OR food intake $0\%\text{--}25\%$ of normal requirements in the preceding week.
2. Severity of Disease / Stress Metabolism (Score 0–3):
   • Mild (1): Hip fracture, chronic hemodialysis, cirrhosis, chronic obstructive pulmonary disease (COPD), oncology.
   • Moderate (2): Major abdominal surgery, stroke, severe pneumonia, hematologic malignancy.
   • Severe (3): Severe head trauma, bone marrow transplantation, intensive care patients with APACHE II score $> 10$.
3. Age Adjustment:
   • If the patient is $\ge 70\text{ years of age}$, add $1\text{ point}$ to the cumulative score to account for reduced physiological reserve.

Clinical Decision Threshold: A total score $\ge 3$ categorizes the patient as being at nutritional risk, mandating the immediate initiation of a comprehensive nutrition assessment and an individualized nutrition care plan.

3. Nutrition Risk in the Critically Ill (NUTRIC) Score

The NUTRIC Score, developed by Heyland and colleagues, is the first nutrition risk screening tool specifically developed and validated for intensive care unit (ICU) patients. Critically ill patients cannot be evaluated using conventional screening metrics because acute fluid resuscitation renders body weight and BMI inaccurate, and obtunded patients cannot report dietary history.

Crucially, the NUTRIC score does not merely diagnose pre-existing malnutrition; it identifies critically ill patients who possess a high risk of adverse clinical outcomes (mortality, prolonged mechanical ventilation) and who demonstrate a statistically significant survival benefit from full, targeted nutrition therapy.

The score incorporates 6 physiological and clinical variables:

• Age: $< 50\text{ years} = 0$; $50\text{--}74\text{ years} = 1$; $\ge 75\text{ years} = 2$.
• APACHE II Score: $< 15 = 0$; $15\text{--}19 = 1$; $20\text{--}27 = 2$; $\ge 28 = 3$.
• SOFA Score: $< 6 = 0$; $6\text{--}9 = 1$; $\ge 10 = 2$.
• Number of Comorbidities: $0\text{--}1 = 0$; $\ge 2 = 1$.
• Days from Hospital Admission to ICU Admission: $0\text{ to } < 1\text{ day} = 0$; $\ge 1\text{ day} = 1$.
• Interleukin-6 (IL-6, optional): $0\text{ to } < 400\text{ pg/mL} = 0$; $\ge 400\text{ pg/mL} = 1$.

Because serum IL-6 is not routinely available in many clinical laboratories, the modified NUTRIC (mNUTRIC) score excludes IL-6 and is scored out of 9 points:

• High Nutritional Risk (Score 6–10 with IL-6, or 5–9 without IL-6): Associated with significantly elevated 28-day mortality. Patients in this category derive a pronounced survival benefit from early enteral nutrition (initiated within 24–48 hours) and meeting $\ge 80\%$ of target caloric and protein goals.
• Low Nutritional Risk (Score 0–5 with IL-6, or 0–4 without IL-6): Permissive underfeeding or trophic feeding during the initial acute phase of critical illness is well-tolerated and not associated with worsened mortality.

4. Mini Nutritional Assessment (MNA) & MNA-SF

The MNA and its validated Short Form (MNA-SF) are designed specifically for geriatric populations ($\ge 65\text{ years}$) across outpatient clinics, assisted living, long-term care, and acute hospitalization. The MNA-SF consists of 6 items evaluated over a 14-point scale:

1. Decline in food intake over the past 3 months (0–2 points)
2. Involuntary weight loss over the past 3 months (0–3 points)
3. Mobility (bed/chair bound, able to get out of bed, goes out; 0–2 points)
4. Psychological stress or acute disease in the past 3 months (0 or 2 points)
5. Neuropsychological problems (dementia or severe depression; 0–2 points)
6. Anthropometry: Body Mass Index (0–3 points). Crucial Clinical Adaptation: In bedridden, amputee, or contracted older adults where height and weight cannot be reliably measured, calf circumference (CC) serves as a validated surrogate ($CC < 31\text{ cm} = 0\text{ points}$; $CC \ge 31\text{ cm} = 3\text{ points}$).

Stratification:

• 12–14 points: Normal nutritional status
• 8–11 points: At risk of malnutrition
• 0–7 points: Malnourished

5. Malnutrition Screening Tool (MST)

The MST is an ultra-rapid, two-question instrument originally developed by Ferguson et al. in Australia and validated across diverse adult inpatient and outpatient settings. Because of its brevity and high sensitivity, it is the primary screening tool recommended by the Academy of Nutrition and Dietetics for adult ambulatory and oncology clinics.

1. Have you lost weight recently without trying? (No = 0; Unsure = 2; Yes $\to$ 1–5 kg = 1, 6–10 kg = 2, 11–15 kg = 3, $> 15\text{ kg} = 4$).
2. Have you been eating poorly because of a decreased appetite? (No = 0; Yes = 1).

A cumulative score $\ge 2$ indicates nutritional risk and triggers immediate referral to a registered dietitian.

---

Comparative Matrix of Validated Screening Instruments

---

Clinical Implementation Challenges and Pitfalls

1. Confounding by Third-Spacing and Edema: Aggressive crystalloid fluid resuscitation, congestive heart failure, and end-stage liver disease falsely elevate body weight and BMI. A patient with severe muscle wasting can present with a "normal" or "elevated" BMI due to 15 liters of ascites and peripheral edema. Clinicians must scrutinize unintentional dry weight loss and acute changes rather than relying solely on admission weight.
2. Failure to Rescreen Negative Screens: Nutrition screening is not a static one-time event. Hospitalized patients who screen negative at admission may develop acute deterioration due to nil per os (NPO) orders, post-operative complications, or sepsis. Institutional policies must mandate routine rescreening at regular intervals (typically every 7 days).
3. Screening Without Actionable Pathways: A screening tool is clinically useless if a positive score does not automatically initiate a documented, auditable clinical pathway connecting nursing triage to dietitian assessment and provider order entry in this independent study resource framework.